Geriatric assessment for older patients after ICU discharge
Geriatric Assessment at Discharge From the Intensive Care Unit in Patients Aged 75 Years and Older: a Feasibility Study
This study tests if giving older patients a check-up after leaving the ICU can help them recover better and improve their quality of life.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 70 (estimated) |
| Ages | 75 Years and up |
| Sex | All |
| Sponsor | University Hospital, Strasbourg, France Academic / other |
| Locations | 1 site (Strasbourg) |
| Trial ID | NCT06513130 on ClinicalTrials.gov |
What this trial studies
This study evaluates the feasibility of conducting geriatric assessments within seven days after discharge from the intensive care unit (ICU) for patients aged 75 and older. It aims to identify the impact of ICU stays on the functional status and quality of life of elderly patients, who are increasingly represented in critical care settings. The study compares outcomes between patients who receive a geriatric assessment and those who do not, focusing on their recovery and overall well-being post-ICU. By understanding these dynamics, the study seeks to improve care strategies for older adults in critical conditions.
Who should consider this trial
Good fit: Ideal candidates are patients aged 75 and older who have survived an ICU admission.
Not a fit: Patients who are moribund or have a life expectancy of less than one month will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the recovery and quality of life for elderly patients after ICU stays.
How similar studies have performed: While similar approaches have been explored, this specific feasibility study focusing on geriatric assessments post-ICU discharge is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients over 75 years of age * Admitted to the intensive care unit, for whatever reason, and having survived their stay, considered as leaving the intensive care unit. * Subjects affiliated to a health insurance scheme * Able to understand the aims and risks of the research and to give dated, signed informed consent, * In the event of confusion on leaving the intensive care unit, a close relative available to give dated, signed informed consent, with the patient's consent collected as soon as his or her condition permits. Exclusion Criteria: * Protected subject as defined by law: safeguard of justice, guardianship or curatorship procedures * Subject moribund, or whose life expectancy as estimated by the clinician in charge is less than 1 month * Patient not living in Bas-Rhin (visit to M6)
Where this trial is running
Strasbourg
- Service de Médecine Intensive - Réanimation / CHU Strasbourg - France — Strasbourg, France (Recruiting)
Study contacts
- Principal investigator: Julien DEMISELLE — Hôpitaux Universitaires de Strasbourg
- Study coordinator: Julien DEMISELLE
- Email: julien.demiselle@chru-strasbourg.fr
- Phone: 0369551079
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.